Nathan Smith’s AI-built portfolio is up 23.8% in four weeks after leveraging ChatGPT. He shares his take on micro-caps, risk, ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.

Senate rejects president’s budget proposal to slash life-saving HIV programs The rare, bipartisan rebuke also increased the budget for the National Institutes of Health by $400 million. 3 minute ...